fentanyl has been researched along with Cancer of Pancreas in 15 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present the case of Allergic Contact Dermatitis (ACD) due to hypersensitivity to fentanyl with good tolerance to buprenorphine." | 7.91 | Allergic Contact Dermatitis to Fentanyl TTS with Good Tolerance to Systemic Fentanyl. ( Albéndiz-Gutiérrez, V; Micozzi, S; Noguerado-Mellado, B; Rodríguez-Fernández, A; Rojas-Pérez-Ezquerra, P; Torrado-Español, I, 2019) |
| "Continuous fentanyl infusion should be considered for the treatment of cancer pain in patients requiring high doses who become refractory to other opioids, when other opioids cause intolerable adverse effects, when patients have a true morphine allergy, or when high-dose requirements threaten to deplete existing stock of alternate opioids." | 7.70 | Continuous fentanyl infusion: use in severe cancer pain. ( Dunlap, DS; Lenz, KL, 1998) |
| "We present the case of Allergic Contact Dermatitis (ACD) due to hypersensitivity to fentanyl with good tolerance to buprenorphine." | 3.91 | Allergic Contact Dermatitis to Fentanyl TTS with Good Tolerance to Systemic Fentanyl. ( Albéndiz-Gutiérrez, V; Micozzi, S; Noguerado-Mellado, B; Rodríguez-Fernández, A; Rojas-Pérez-Ezquerra, P; Torrado-Español, I, 2019) |
| "Continuous fentanyl infusion should be considered for the treatment of cancer pain in patients requiring high doses who become refractory to other opioids, when other opioids cause intolerable adverse effects, when patients have a true morphine allergy, or when high-dose requirements threaten to deplete existing stock of alternate opioids." | 3.70 | Continuous fentanyl infusion: use in severe cancer pain. ( Dunlap, DS; Lenz, KL, 1998) |
| "EUS-CPN for patients with pancreatic cancer-associated pain did not appear to improve pain, QOL, or opioid consumption compared with those who did not undergo EUS-CPN and medicated with oxycodone/fentanyl." | 2.94 | Efficacy of EUS-guided celiac plexus neurolysis compared with medication alone for unresectable pancreatic cancer in the oxycodone/fentanyl era: a prospective randomized control study. ( Ito, K; Kanno, Y; Koshita, S; Kozakai, F; Kusunose, H; Masu, K; Murabayashi, T; Ogawa, T; Sakai, T, 2020) |
| "Cancer pain is a significant issue in terminally ill cancer patients (TICPs)." | 1.91 | Differences in Fentanyl Requirements in Terminally Ill Cancer Patients. ( Fujiwara, N; Ishiki, H; Nojima, M; Shimada, N; Tojo, A; Watanabe, A, 2023) |
| "Pancreatic cancer is one of the most aggressive cancer due to the late diagnosis and failure to respond to the treatment despite advances in tumor biology and the development of new cancer therapeutic strategies." | 1.51 | Effects of Fentanyl on pancreatic cancer cell proliferation and cancer stem cell differentiation. ( Celik, F; Duran, T, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, WH | 1 |
| Liu, XJ | 1 |
| Zhao, LY | 1 |
| Lin, SY | 1 |
| Teng, L | 1 |
| Dai, JZ | 1 |
| Shao, HX | 1 |
| Zou, HC | 1 |
| Watanabe, A | 2 |
| Shimada, N | 2 |
| Ishiki, H | 2 |
| Fujiwara, N | 2 |
| Nojima, M | 2 |
| Tojo, A | 2 |
| Celik, F | 1 |
| Duran, T | 1 |
| Kanno, Y | 2 |
| Koshita, S | 2 |
| Masu, K | 1 |
| Ogawa, T | 1 |
| Kusunose, H | 1 |
| Murabayashi, T | 1 |
| Sakai, T | 1 |
| Kozakai, F | 1 |
| Ito, K | 2 |
| Marya, NB | 1 |
| Levy, MJ | 1 |
| Gao, Y | 1 |
| Zhao, X | 1 |
| Rojas-Pérez-Ezquerra, P | 1 |
| Micozzi, S | 1 |
| Torrado-Español, I | 1 |
| Rodríguez-Fernández, A | 1 |
| Albéndiz-Gutiérrez, V | 1 |
| Noguerado-Mellado, B | 1 |
| Michel-Lauter, B | 1 |
| Bernardy, K | 1 |
| Schwarzer, A | 1 |
| Nicolas, V | 1 |
| Maier, C | 1 |
| Sutou, I | 1 |
| Nakatani, T | 1 |
| Hashimoto, T | 1 |
| Saito, Y | 1 |
| Matsuyama, K | 1 |
| Satomi, E | 1 |
| Ueno, H | 1 |
| Inoue, A | 1 |
| Oike, M | 1 |
| Todaka, K | 1 |
| Yoshida, T | 1 |
| Sekiyama, R | 1 |
| Hirotsune, H | 1 |
| Sueta, K | 1 |
| Miyamoto, A | 1 |
| Nakamori, S | 1 |
| Tsujinaka, T | 1 |
| Komori, K | 1 |
| Seccareccia, D | 1 |
| Edinboro, LE | 1 |
| Poklis, A | 1 |
| Trautman, D | 1 |
| Lowry, S | 1 |
| Backer, R | 1 |
| Harvey, CM | 1 |
| Lenz, KL | 1 |
| Dunlap, DS | 1 |
| Abe, M | 1 |
| Takahashi, M | 1 |
| Yabumoto, E | 1 |
| Onoyama, Y | 1 |
| Torizuka, K | 1 |
1 review available for fentanyl and Cancer of Pancreas
| Article | Year |
|---|---|
Pain patch.
Topics: Abdominal Pain; Administration, Cutaneous; Aged; Analgesics, Opioid; Confusion; Disorders of Excessi | 2007 |
1 trial available for fentanyl and Cancer of Pancreas
| Article | Year |
|---|---|
Efficacy of EUS-guided celiac plexus neurolysis compared with medication alone for unresectable pancreatic cancer in the oxycodone/fentanyl era: a prospective randomized control study.
Topics: Abdominal Pain; Celiac Plexus; Endosonography; Fentanyl; Humans; Oxycodone; Pancreatic Neoplasms; Pr | 2020 |
13 other studies available for fentanyl and Cancer of Pancreas
| Article | Year |
|---|---|
[The impact of the dosage of intraoperative opioids on postoperative survival outcomes in patients with pancreatic cancer].
Topics: Analgesics, Opioid; Fentanyl; Humans; Pancreatic Neoplasms; Retrospective Studies | 2022 |
[The impact of the dosage of intraoperative opioids on postoperative survival outcomes in patients with pancreatic cancer].
Topics: Analgesics, Opioid; Fentanyl; Humans; Pancreatic Neoplasms; Retrospective Studies | 2022 |
[The impact of the dosage of intraoperative opioids on postoperative survival outcomes in patients with pancreatic cancer].
Topics: Analgesics, Opioid; Fentanyl; Humans; Pancreatic Neoplasms; Retrospective Studies | 2022 |
[The impact of the dosage of intraoperative opioids on postoperative survival outcomes in patients with pancreatic cancer].
Topics: Analgesics, Opioid; Fentanyl; Humans; Pancreatic Neoplasms; Retrospective Studies | 2022 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Differences in Fentanyl Requirements in Terminally Ill Cancer Patients.
Topics: Analgesics, Opioid; Cancer Pain; Female; Fentanyl; Humans; Male; Neoplasms; Pancreatic Neoplasms; Re | 2023 |
Effects of Fentanyl on pancreatic cancer cell proliferation and cancer stem cell differentiation.
Topics: Cell Line; Cell Line, Tumor; Cell Proliferation; Fentanyl; Flow Cytometry; Humans; Inhibitory Concen | 2019 |
Celiac plexus neurolysis versus opioid analgesic therapy: Are we still guided by the presumptions?
Topics: Analgesics, Opioid; Celiac Plexus; Fentanyl; Humans; Oxycodone; Pancreatic Neoplasms; Prospective St | 2020 |
EUS-guided celiac plexus neurolysis versus medication alone for unresectable pancreatic cancer.
Topics: Celiac Plexus; Fentanyl; Humans; Oxycodone; Pancreatic Neoplasms; Prospective Studies | 2020 |
Response.
Topics: Celiac Plexus; Fentanyl; Humans; Oxycodone; Pancreatic Neoplasms; Prospective Studies | 2020 |
Allergic Contact Dermatitis to Fentanyl TTS with Good Tolerance to Systemic Fentanyl.
Topics: Administration, Cutaneous; Buprenorphine; Dermatitis, Allergic Contact; Drug Hypersensitivity; Drug | 2019 |
[Dependency syndrome and hyperalgesia due to an opioid therapy for curative treatable pain. Case report of an apparent palliative patient].
Topics: Activities of Daily Living; Administration, Cutaneous; Administration, Intranasal; Aged; Analgesics, | 2013 |
Fentanyl tolerance in the treatment of cancer pain: a case of successful opioid switching from fentanyl to oxycodone at a reduced equivalent dose.
Topics: Analgesics, Opioid; Drug Substitution; Fentanyl; Humans; Male; Middle Aged; Oxycodone; Pain; Pain Ma | 2015 |
[A case of unresectable advanced pancreatic cancer treated by gemcitabine-based chemotherapy following cancer pain alleviation by low-dose matrix-type transdermal fentanyl].
Topics: Administration, Cutaneous; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Fentanyl; G | 2009 |
Fatal fentanyl intoxication following excessive transdermal application.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Analgesics, Opioid; Carcinoma; Fatal Outcome; Fe | 1997 |
Continuous fentanyl infusion: use in severe cancer pain.
Topics: Aged; Analgesics, Opioid; Anesthetics, Intravenous; Fatal Outcome; Female; Fentanyl; Humans; Infusio | 1998 |
Techniques, indications and results of intraoperative radiotherapy of advanced cancers.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Alcuronium; Anesthesia, Inhalation; Anesthesia, Intravenous | 1975 |